Gower Street
London, WC1E 6BT
United States
Cholangiocarcinomaadjuvantcapecitabine
Cholangiocarcinoma; IDH1 mutation; Ivosidenib; Phase 3 study
Pancreatic cancer, Chemoradiotherapy, Nelfinavir, Dose escalation, Survival, Outcomes, Toxicity, Health-related quality of life
COVID-19; oncology; SARS-CoV-2; coronavirus; cancer; tumour; systemic anticancer treatment; novel coronavirus; SACT; chemotherapy; immunotherapy; hormone therapy; targeted treatment
biliary tract, advanced, second-line, chemotherapy, FOLFOX